SCHEMBL23818531

SCHEMBL23818531

N#C[C@@]1(CO[PH](=O)Oc2ccccc2)CC[C@H](c2ccc3c(N)ncnn23)O1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.34
▸ TNK2 Q07912 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818844 0.86 POLRMT (0.35) POLRMTTNK2
SCHEMBL23843995 0.84 POLRMT (0.34) POLRMT
SCHEMBL26289321 0.83 POLRMT (0.36) POLRMTTNK2
SCHEMBL23818802 0.82 POLRMT (0.31) POLRMT
SCHEMBL23818812 0.81 POLRMT (0.39) POLRMT
SCHEMBL26237975 0.80 TNK2 (0.35) POLRMTTNK2
SCHEMBL23819195 0.79 POLRMT (0.43) POLRMTTNK2
SCHEMBL26237826 0.79 POLRMT (0.35) POLRMT
SCHEMBL25077083 0.78 POLRMT (0.35) POLRMT
SCHEMBL26237462 0.78 POLRMT (0.34) POLRMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284670-A1 ANTIVIRAL COMPOUNDS MAVS, HAVCR2, ZC3HAV1 POLRMT 535/4885TNK2 4420/4885
US-11767337-B2 Antiviral compounds MAVS, HAVCR2, ZC3HAV1 POLRMT 535/4885TNK2 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback